close this section of the library7. Economics and Financing
open this document and view contentsGlobalización y acceso a los medicamentos (OMS/EDM, 2000, 129 p.)
open this document and view contentsGlobalization and access to drugs (WHO/EDM, 1999, 97 p.)
open this document and view contentsMondialisation et accès aux médicaments (OMS/DAP, 1999, 118 p.)
open this document and view contentsPublic-private roles in the pharmaceutical sector: Implications for equitable access and rational drug use (WHO/DAP, 1997, 115 p.)
open this document and view contentsRéformes de la santé et financement des médicaments (OMS/DAP, 1998, 60 p.)
open this document and view contentsRôles des secteurs public et privé dans le domaine pharmaceutique: Incidences sur l'équité en matière d'accès et sur l'usage rationnel des médicaments (OMS/DAP, 1997, 126 p.)
open this document and view contentsSelected topics in health reform and drug financing (WHO/DAP, 1998, 49 p.)
open this document and view contentsStudy of the implications of the WTO TRIPS Agreement fotr the pharmaceutical industry in Thailand (The Centre for Health Economics, Faculty of Economics, Chulalongkorn University Bangkok - WHO Collaborating Centre for Health Economics - WHO/SEARO, 1999, 113 p.)
open this document and view contentsThe TRIPS Agreement and pharmaceuticals (Directorate General of Drug and Food Control - Indonesia - WHO, 2000, 91 p.)